Bedside Evaluation of Coagulation in Children With Congenital Heart

Status Completed

Clinical Trial Summary

The purpose of this study is to assess coagulation and platelet function in children with congenital heart disease, measured with a bedside device (thromboelastometry and impedance aggregometry).

The investigators also aim to determine if this device detect post-cardiopulmonary bypass clotting derangements and may help to manage bleeding in this population.

Clinical Trial Description

Hemostasis, a main concern during and after any surgical procedure, is traditionally monitored by the following laboratory tests: activated Partial Thrombin Time (aPTT), prothrombin time (PT), fibrinogen, platelets count. They neither provide a reliable estimate of the risk of bleeding, nor allow determining useful interventions.

New investigations of hemostasis are now used and validated during and after surgery: Rotational Thromboelastometry (ROTEM®) and impedance aggregometry. This is a quick bedside functional analysis of the patient's clotting. Children who undergo surgery under cardiopulmonary bypass (CPB) are particularly at risk of bleeding and this population hasn't been studied with large cohort yet.

Hypothesis: Hemostasis in children with CHD, especially when cyanotic, is intrinsically abnormal. The corrective surgery on CPB induces further hemostatic disorders which can be identified by the ROTEM platelet®.

The aim of the study is to evaluate the hemostatic function of the child with congenital heart disease using a Point-Of-Care (platelet-ROTEM ®) system, before surgery and after alterations induced by cardiopulmonary bypass (CPB).

This is a single center, observational, prospective study. Expected duration: 2 years. The investigators plan to include 200 patients with CHD, 100 patients undergoing surgery with CPB and 100 patients with congenital heart disease requiring cardiac catheterization. Recruitment will be conducted by the Division of Paediatric Cardiology.

Inclusion criteria include an age of 0-16 years and a diagnosis of congenital heart disease requiring surgery with CPB or cardiac catheterization. Patients with known dyscrasia or treated with antiaggregant within 10 days/oral anticoagulants within 48h before surgery/catheterization.

ROTEM platelet® test will be performed before surgery/catheterization. Patients undergoing surgery will have a second test within 30 minutes after the end of cardiopulmonary bypass. All patients will benefit from the usual cares. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02387944
Study type	Observational
Source	Centre Hospitalier Universitaire Vaudois
Contact
Status	Completed
Phase	N/A
Start date	March 2015
Completion date	July 7, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04136379` - Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
Recruiting	`NCT02258724` - Swiss National Registry of Grown up Congenital Heart Disease Patients
Completed	`NCT01212289` - Use of ROTEM® in Pediatric Cardiac Surgical Patients	N/A
Completed	`NCT04090827` - The Transitioning Rural Adolescents to Adult Care Study	N/A
Completed	`NCT03311438` - Oral Health Intervention Program for Children With Congenital Heart Defects	N/A
Active, not recruiting	`NCT04271358` - Peer Coaching Intervention in Young Adults With Congenital Heart Disease	N/A
Terminated	`NCT00451698` - Erythropoietin and Pediatric Cardiac Surgery	N/A
Recruiting	`NCT04106479` - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Recruiting	`NCT04437069` - Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making	N/A
Completed	`NCT04106154` - Impacting Children's Physical and Mental Health Through Kinesiology Support in Clinical Care	N/A
Recruiting	`NCT03297658` - Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.	N/A
Recruiting	`NCT04619745` - A Feasibility Study of Physical Activity After Surgical or Catheterization Intervention	N/A
Recruiting	`NCT03512613` - A Pilot Study- Monitoring Cerebral Blood Flow in Neonates With Congenital Heart Defects
Recruiting	`NCT05698277` - Automated Fetal Cardiac Function in Babies Affected by Heart Diseases
Completed	`NCT04056416` - Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)	N/A
Active, not recruiting	`NCT03110861` - Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study	N/A
Completed	`NCT03348397` - Contegra Versus Pulmonary Homograft for Right Ventricular Outflow Tract Reconstruction in Newborns	N/A
Completed	`NCT02968264` - Tetralogy of Fallot for Life
Completed	`NCT03611374` - Regional Anesthesia for Cardiothoracic Enhanced Recovery (RACER) Study	N/A
Completed	`NCT03143348` - Prognostic Markers of Inflammation in Infants Undergoing Cardiopulmonary Bypass

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease — POCHEMO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms